• Neuronetics Inc STIM.OQ STIM.O is expected to show a rise in quarterly revenue when it reports results on May 6 for the period ending March 31 2025

• The Malvern Pennsylvania-based company is expected to report a 66.9% increase in revenue to $29.068 million from $17.42 million a year ago, according to the mean estimate from 4 analysts, based on LSEG data.The company's guidance on March 4 2025, for the period ended March 31, was for revenue between $28.00 million and $30.00 million.

• ​LSEG's mean analyst estimate for Neuronetics Inc is for a loss of 12 cents per share.

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell."

• The mean earnings estimate of analysts was unchanged in the last three months. ​

• Wall Street's median 12-month price target for Neuronetics Inc is $7.00​, above​ its last closing price of $4.46. ​​​

Previous quarterly performance (using preferred earnings measure in US dollars). ​

This summary was machine generated May 2 at 13:36 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)